AK
Archana Kulkarni-Munje
Fortrea, Fitterfly Health Tech Pvt Ltd, Savitribai Phule Pune University, Bharati Vidyapeeth (Deemed to be University) Interactive Research School for Health Affairs
Employment
-
Fortrea Medical writerII2024 - Present
-
Fitterfly Health Tech Pvt Ltd2022 - 2024
-
Bharati Vidyapeeth (Deemed to be University) Interactive Research School for Health Affairs Assistant professor2019 - 2022
-
Interactive Research School for Health Affairs Research Associate2017 - 2019
-
National AIDS Research Institute Research Associate2014 - 2017
Education
-
Savitribai Phule Pune University PhD2009 - 2014
Projects & Funding
Projects & funding information is unavailable.
Publications (15)
- Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework Save
- Effect of Personalized Exercise Interventions from the Fitterfly Diabetes Digital Therapeutics Program in Type 2 Diabetes: Real-world Effectiveness Evaluation (Preprint) Save
- Dual pattern recognition receptor ligands CL401, CL413, and CL429 as adjuvants for inactivated chikungunya virus Save
- Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital Save
- Immune Response of Indian Preterm Infants to Pentavalent Vaccine Varies With Component Antigens and Gestational Age. Save
- Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity. Save
- Immunogenicity of Two COVID-19 Vaccines Currently Used in India: Experience in Health Care Workers From a Tertiary Care Hospital Save
- Short Communication: Nonprogressive HIV-1 Infection Is Associated with Expansion of IL-21R Expressing Class-Switched Memory B Cells. Save
- Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity-mediating antibodies in HIV-infected Indian individuals Save
- Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts Save